SICKLE CELL DISEASE (SCD)
Clinical trials for SICKLE CELL DISEASE (SCD) explained in plain language.
Never miss a new study
Get alerted when new SICKLE CELL DISEASE (SCD) trials appear
Sign up with your email to follow new studies for SICKLE CELL DISEASE (SCD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with sickle cell: drug aims to cut painful crises
Disease control CompletedThis study tested a drug called crizanlizumab in 117 children aged 2 to 18 with sickle cell disease who have had painful vaso-occlusive crises. The goal was to find the right dose and check safety, with some children also taking hydroxyurea. The drug works by blocking a protein i…
Matched conditions: SICKLE CELL DISEASE (SCD)
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New drug crizanlizumab tested for safety in indian sickle cell patients
Disease control CompletedThis study tested the safety of a drug called crizanlizumab in 140 Indian patients aged 16 and older with sickle cell disease who have had painful crises. The drug was given by IV infusion over several months, with or without standard hydroxyurea therapy. The main goal was to che…
Matched conditions: SICKLE CELL DISEASE (SCD)
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
ER wait after admission costs millions, study finds
Knowledge-focused CompletedThis study looked at over 30,000 adults admitted to hospitals in Maryland to understand why some patients wait in the emergency room even after being admitted (called boarding). Researchers wanted to find out what patient traits lead to longer waits, how boarding increases health…
Matched conditions: SICKLE CELL DISEASE (SCD)
Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC